These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2838861)

  • 1. Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes.
    Gleiter CH; Nutt DJ
    Psychopharmacology (Berl); 1988; 95(1):68-70. PubMed ID: 2838861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.
    Edwards E; Harkins K; Wright G; Henn F
    J Neurochem; 1991 May; 56(5):1581-6. PubMed ID: 1826517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic serotonin mechanisms in rats subjected to inescapable shock.
    Edwards E; Kornrich W; Houtten PV; Henn FA
    Neuropharmacology; 1992 Apr; 31(4):323-30. PubMed ID: 1387924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of [3H]paroxetine binding to rat cortical membranes.
    Habert E; Graham D; Tahraoui L; Claustre Y; Langer SZ
    Eur J Pharmacol; 1985 Nov; 118(1-2):107-14. PubMed ID: 2935409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM; Grondin L; Carli M; Lima L; Reader TA
    J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor.
    Gleiter CH; Nutt DJ
    Adv Alcohol Subst Abuse; 1988; 7(3-4):107-11. PubMed ID: 2975918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Hashimoto K; Goromaru T
    Neuropharmacology; 1991 Feb; 30(2):113-7. PubMed ID: 2030818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
    Marcusson J; Eriksson K
    J Neurochem; 1988 Nov; 51(5):1477-81. PubMed ID: 2971784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
    Scheffel U; Hartig PR
    J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
    Laruelle M; Vanisberg MA; Maloteaux JM
    Biol Psychiatry; 1988 Jul; 24(3):299-309. PubMed ID: 2969755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-sensitive high affinity [3H]serotonin binding: characterization and effects of antidepressant treatment.
    Helmeste DM; Tang SW
    Life Sci; 1984 Aug; 35(7):759-67. PubMed ID: 6472055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.